Loading...
162 Asia Active Pharmaceutical Ingredients Reports
Region Covered: Asia
Study Period: 2019 - 2029
Countries Covered: China, Japan, India, Australia, South Korea
Major Players: AbbVie Inc, Aspen Holdings, Baxter International, Fresenius SE & Co. KGaA, B. Braun SE
Region Covered: Asia
Study Period: 2018 - 2029
Countries Covered: Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, Thailand, Vietnam
Major Players: AstraZeneca, Eli Lilly and Company, Merck and Co., Novartis AG, Bristol-Myers Squibb
Country Covered: India
Study Period: 2019 - 2029
Major Players: Aurobindo Pharma, Lupin Ltd, Viatris Inc., Sun Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd
Country Covered: India
Study Period: 2019 - 2029
Major Players: Dabur India Ltd, Himalaya Wellness, Sydler Remedies Pvt Ltd, Baidyanath, Patanjali Ayurved Limited
Region Covered: Asia
Study Period: 2018 - 2029
Countries Covered: Japan, China, South Korea, India, Australia, Malaysia, Indonesia, Philippines, Thailand
Major Players: Takeda, Pfizer, Bayer, Sun Pharma, Glenmark
Region Covered: Asia
Study Period: 2018 - 2029
Countries Covered: Japan, South Korea, China, India, Australia, Vietnam, Malaysia, Indonesia, Philippines, Thailand
Major Players: Eli Lilly, Boehringer Ingelheim, Janssen Pharmaceuticals, AstraZeneca, Bristol Myers Squibb
Region Covered: Asia
Study Period: 2019 - 2029
Countries Covered: Japan, South Korea, China, India, Australia, Vietnam, Malaysia, Indonesia, Philippines, Thailand
Major Players: Takeda, Bristol-Myers Squibb, Glenmark, Merck and Co., Sanofi Aventis
Region Covered: Asia
Study Period: 2018 - 2029
Countries Covered: Japan, China, Australia, India, South Korea, Malaysia, Indonesia, Thailand, Philippines, Vietnam
Major Players: AstraZeneca, Eli Lilly and Company, Novo Nordisk A/S, Sanofi Aventis, Biocon Ltd.
Region Covered: Asia
Study Period: 2019-2029
Countries Covered: Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, Thailand, Vietnam
Major Players: Novo Nordisk, Eli Lilly, Sanofi, Biocon, Gan & Lee
Region Covered: Asia
Study Period: 2018 - 2029
Countries Covered: Japan, China, South Korea, India, Australia, Malaysia, Indonesia, Philippines, Thailand
Major Players: Novo Nordisk, Glenmark, Novartis, Kissei, Biocon
Country Covered: China
Study Period: 2019 - 2029
Major Players: WuXi AppTec (WuXi STA), Asymchem Laboratories, Reyoung Pharmaceutical, Zhejiang NHU Co., Ltd., CSPC Pharmaceutical Group Limited (Shijiazhuang Pharmaceutical Group Co., Ltd)
Region Covered: Asia
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: CSL Behring LLC, Takeda Pharmaceutical Company Limited (Shire Pharmaceutical Holdings), Pharming Technologies B.V., KalVista Pharmaceuticals, Inc., BioCryst Pharmaceuticals
Region Covered: Asia
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, United Kingdom, France, Germany, Italy, Spain, India, China, Japan, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Abbott Laboratories, AstraZeneca PLC, Bayer Ag, Boehringer Ingelheim International GmbH, Amgen Inc.
Region Covered: Asia
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Johnson & Johnson, Mankind Pharma, Pfizer Inc, Dr.Morepen, Smith & Nephew Plc
Region Covered: Asia
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Pfizer Inc. , AA Pharma Inc. , GSK plc, Viatris Inc, Teva Pharmaceutical Industries Ltd
Region Covered: Asia
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: ACG Worldwide, Capscanada Corporation, Medi-Caps Ltd, Bright Pharma Caps Inc, Lonza Group(Capsugel)
Region Covered: Asia
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Merck & Co., Inc, Gilead Sciences, GlaxoSmithKline PLC, Pfizer Inc, Novartis AG
Region Covered: Asia
Study Period: 2020 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Abbott Laboratories, Bayer AG, Merck & Co., Inc., Glenmark Pharmaceuticals Limited, GSK plc
Region Covered: Asia
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Abbott Laboratories, Becton, Dickinson and Company, Boston Scientific Corporation, Johnson and Johnson , Baxter International Inc. (Avante Health Solutions)
Region Covered: Asia
Study Period: 2021 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Pfizer Inc., Abbvie Inc., Silvergate Pharmaceuticals Inc., Novartis AG, GlaxoSmithKline
Region Covered: Asia
Study Period: 2021 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: AstraZeneca, Amgen, Pfizer, AbbVie Inc, Teva Pharmaceuticals
Region Covered: Asia
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: GlaxoSmithKline plc, Amgen Inc., Novartis AG, AbbVie Inc., F. Hoffmann-La Roche AG
Region Covered: Asia
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea
Major Players: AbbVie Inc , Amgen Inc , Cadila Healthcare Ltd , Hetero Healthcare Limited, Pfizer Inc
Region Covered: Asia
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Baxter International Inc., Aspen Pharmacare Holdings Limited, B. Braun Melsungen AG, Fresenius SE & Co. KGaA, Pfizer Inc.
Region Covered: Asia
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea
Major Players: Covaris Inc., Microfluidics (IDEX Corporation), Allergan PLC, Ascendia Pharmaceuticals, Owen Biosciences, Inc
Region Covered: Asia
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: AbbVie, Inc, Johnson and Johnson, Novartis AG, Eli Lilly and Company, GlaxoSmithKline Plc
Region Covered: Asia
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: AbbVie Inc., Bristol-Myers Squibb Company, Gilead Sciences Inc., F. Hoffman-La Roche Ltd, Cipla Inc.
Region Covered: Asia
Study Period: 2021 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: GlaxoSmithKline PLC, Sanofi, AstraZeneca, Eli Lilly and Company, Pfizer Inc.
Region Covered: Asia
Study Period: 2021 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Gilead Sciences, Inc., Merck & Co, Inc., GlaxoSmithKline plc (ViiV Healthcare)
Region Covered: Asia
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Galderma S.A., LG Chem Ltd., Syner-Med (Pharmaceutical Products) Ltd., Anika Therpeutics Inc., Zydus Cadila Pharmaceuticals Ltd.
Filter Reports
By Countries